Azilsartan vs Telmisartan - Which is better for raised Blood Pressure?

Azilsartan vs Telmisartan - Which is better for raised Blood Pressure?

EnglishPaperback / softback
Garg, Megha
LAP Lambert Academic Publishing
EAN: 9786139986071
On order
Delivery on Tuesday, 7. of January 2025
CZK 1,408
Common price CZK 1,564
Discount 10%
pc
Do you want this product today?
Oxford Bookshop Praha Korunní
not available
Librairie Francophone Praha Štěpánská
not available
Oxford Bookshop Ostrava
not available
Oxford Bookshop Olomouc
not available
Oxford Bookshop Plzeň
not available
Oxford Bookshop Brno
not available
Oxford Bookshop Hradec Králové
not available
Oxford Bookshop České Budějovice
not available
Oxford Bookshop Liberec
not available

Detailed information

As per the 2017 American College of Cardiology and American Heart Association guidelines, a blood pressure 130/80 mmHg is considered as hypertension. Ambulatory Blood Pressure Monitoring (ABPM) provides automated measurements of blood pressure over a 24-hour period while patients are engaging in their usual activities. Angiotensin Receptor Blockers (ARBs) inhibit the action of angiotensin II by binding directly to angiotensin 1 receptor and are most tolerated. Various studies have evaluated the efficacy and safety profile of Azilsartan medoxomil (AZL-M) and Telmisartan (TEL) in comparison to other ARBs or Angiotensin Converting Enzyme Inhibitors. Aim of this study was evaluate the efficacy and safety of Azilsartan medoxomil versus Telmisartan using Ambulatory Blood Pressure Monitoring, in approved doses.
EAN 9786139986071
ISBN 6139986079
Binding Paperback / softback
Publisher LAP Lambert Academic Publishing
Publication date February 7, 2019
Pages 96
Language English
Dimensions 229 x 152 x 6
Readership General
Authors Garg, Megha; Sethi, Aseem; Varshney, Rohit Kumar